Tag: Evidence based medicine

Clinical practice guidelines, which dictate treatment standards, influence a significant portion of medical decisions. A core component of these guidelines is determining 'What does first line medication mean?'. It refers to the initial, preferred, and most commonly recommended treatment for a specific medical condition.

An estimated 5% to 8% of unplanned hospital admissions are due to medication issues, emphasizing the importance of medicines optimisation. The four principles of medicines optimisation, developed by the Royal Pharmaceutical Society and endorsed by organizations like NICE, provide a robust framework for healthcare professionals to maximize therapeutic benefits and minimize harm.

The global intravenous hydration therapy market was valued at over $2.64 billion in 2024, fueled by consumer interest in wellness [1.2.2]. This rapid growth raises a critical question for many: Are IV infusions worth the money for the average person?

Despite thousands of studies on its active compound, curcumin, a major barrier to its clinical use is its poor bioavailability [1.3.6, 1.6.7]. This article explains the primary reasons why don't doctors prescribe turmeric as a mainstream medical treatment.

For decades, medical students were taught the MONA mnemonic (Morphine, Oxygen, Nitroglycerin, Aspirin) as the standard first-line treatment for acute coronary syndrome (ACS). However, thanks to the evolution of evidence-based medicine and landmark research, this protocol has been deemed obsolete and potentially harmful. The compelling question for many in healthcare is, **why is Mona not used anymore?**

According to the American Association of Poison Control Centers, the rate of deaths from unintentional poisoning in children under six has dramatically decreased over the decades, leading experts to re-evaluate older interventions like ipecac. The reasons why ipecac is not used anymore are rooted in safety, efficacy, and the development of better alternatives.

In medical education, a clinical pearl is a small, free-standing bit of clinically relevant information based on experience or observation [1.2.5, 1.2.8]. This article explains **what is a pearl in medicine**, its origins, and its significant role in fields like pharmacology.

An estimated 80% of people worldwide use herbal medicines as part of their primary healthcare. Yet, despite its popularity and traditional use, the medical community's stance on ashwagandha remains one of caution, leading many to question, 'Why don't doctors recommend ashwagandha?' This article explores the scientific rationale behind their professional reluctance.

Despite global sales of Coenzyme Q10 (CoQ10) reaching hundreds of millions of dollars, many people wonder: **Why don't doctors recommend CoQ10?**. The reluctance among physicians stems from a complex intersection of limited and conflicting research, regulatory loopholes, and patient safety concerns, positioning it differently from standard prescription drugs.